…[two-year-old] psychedelics start-up targets schizophrenia…
The two-year-old company [states it]… has been tested on 508 people across nine clinical trials… and it has also been tested on rats. Results of the clinical trials have not been published. “RL-007”, previously called FSV7-007, has exhibited a modulating effect on three mechanisms that are central to learning and memory: the cholinergic, NMDA and…
Recent Comments